ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

IL13-PE38 Looks Promising In Early Tests Against Gioma

September 27, 2002

NSABP Donates Sculpture to NIH to Commemorate 50th Year.

September 19, 2008

In Brief: Alice Fordyce, Supporter of Medical Research, Dead At 86; Broder Awarded Block Lectureship

September 18, 1992

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999

When Screening Mammography Meets Health Care Reform, Opinions Proliferate

February 4, 1994